mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
In this study, mRNA COVID-19 vaccination was safe and did not exacerbate the autoimmune disease nor triggered neural autoantibodies or immune-mediated neurologic disorders. The outcome of patients who developed SARS-CoV-2 infection was favorable.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Blanco, Y., Escudero, D., Lleixa, C., Llufriu, S., Egri, N., Garcia, R. R., Alba, M., Aguilar, E., Artola, M., Aldea Novo, M., Alvarez, S., Caballero, E., Cabrera-Maqueda, J. M., Fonseca, E., Guasp, M., Hernando, A., Martinez-Hernandez, E., Olive-Cirera, Tags: All Immunology, Autoimmune diseases, COVID-19, Multiple sclerosis Research Article Source Type: research
More News: Allergy & Immunology | Autoimmune Disease | Brain | Covid Vaccine | COVID-19 | Gilenya | Multiple Sclerosis | Neurology | SARS | Study | Vaccines